Recent insights into human bronchial proteomics – how are we progressing and what is next?

References

• Kleinstreuer C, Zhang Z. Airflow and particle transport in the human respiratory system. Annu Rev Fluid Mech. 2010;42:301–334.
   Web of Science ®Google Scholar
• Sznitman J. Respiratory microflows in the pulmonary acinus. J Biomech. 2013;46:284–298.
   PubMed Web of Science ®Google Scholar
• Ng AW, Bidani A, Heming TA. Innate host defense of the lung: effects of lung-lining fluid pH. Lung. 2004;182:297–317.
   PubMed Web of Science ®Google Scholar
• Stanke F. The contribution of the airway epithelial cell to host defense. Mediators Inflamm. 2015;2015:463016.
   PubMed Web of Science ®Google Scholar
• Moroz VV, Golubev AM, Kuzovlev AN, et al. Clara cell protein (club cell protein) is a new diagnostic molecular candidate biomarker in nosocomial pneumonia. Gen Reanimatology. 2014;10:6–14.
   Google Scholar
• Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res. 2001;2:33–46.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Bai C, Wang X. Potential significance of telocytes in the pathogenesis of lung diseases. Expert Rev Respir Med. 2012;6:45–49.
   PubMed Web of Science ®Google Scholar
• Nagar JK, Akolkar AB, Kumar R. A review on airborne particulate matter and its sources, chemical composition and impact on human respiratory system. Int J Environ Sci. 2014;5:447–463.
   Google Scholar
• Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. J Am Med Assoc. 2014;311:183–192.
   PubMed Web of Science ®Google Scholar
• Chan EH, Brewer TF, Madoff LC, et al. Global capacity for emerging infectious disease detection. Proc Natl Acad Sci USA. 2010;107:21701–21706.
   PubMed Web of Science ®Google Scholar
• The top 10 causes of death [Internet]. World Health Organization. [updated 2017 Jan; cited 2017 Oct]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/
   Google Scholar
• Hassanein M, Callison JC, Callaway-Lane C, et al. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res. 2012;5:992–1006.
   PubMed Web of Science ®Google Scholar
• Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45:928–952.
   PubMed Web of Science ®Google Scholar
• Lau AT, Chiu JF. Biomarkers of lung-related diseases: current knowledge by proteomic approaches. J Cell Physiol. 2009;221:535–543.
   PubMed Web of Science ®Google Scholar
• Terracciano R, Pelaia G, Preianò M, et al. Asthma and COPD proteomics: current approaches and future directions. Proteomics Clin Appl. 2015;9:203–220.
   PubMed Web of Science ®Google Scholar
• Ishizaka A, Watanabe M, Yamashita T, et al. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med. 2001;29:896–898.
   PubMed Web of Science ®Google Scholar
• Pillai DK, Sankoorikal BJ, Johnson E, et al. Directional secretomes reflect polarity-specific functions in an in vitro model of human bronchial epithelium. Am J Respir Cell Mol Biol. 2014;50:292–300.
   PubMed Web of Science ®Google Scholar
• Aufderheide M, Förster C, Beshay M, et al. A new computer-controlled air–liquid interface cultivation system for the generation of differentiated cell cultures of the airway epithelium. Exp Toxicol Pathol. 2016;68:77–87.
   PubMed Web of Science ®Google Scholar
• Hu R, Huffman KE, Chu M, et al. Quantitative secretomic analysis identifies extracellular protein factors that modulate the metastatic phenotype of non-small cell lung cancer. J Proteome Res. 2016;15:477–486.
   PubMed Web of Science ®Google Scholar
• Malard V, Chardan L, Roussi S, et al. Analytical constraints for the analysis of human cell line secretomes by shotgun proteomics. J Proteomics. 2012;75:1043–1054.
   PubMed Web of Science ®Google Scholar
• Li LP, Lu CH, Chen ZP, et al. Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer. Proteomics. 2011;11:429–439.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genom Proteom Bioinformat. 2015;13:17–24.
   PubMed Web of Science ®Google Scholar
• Gharib SA, Vaisar T, Aitken ML, et al. Mapping the lung proteome in cystic fibrosis. J Proteome Res. 2009;8:3020–3028.
   PubMed Web of Science ®Google Scholar
• Pankow S, Bamberger C, Calzolari D, et al. ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature. 2015;528:510–516.
   PubMed Web of Science ®Google Scholar
• Sudhir PR, Hsu CL, Wang MJ, et al. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas. PLoS One. 2011;6:e20199.
   PubMed Web of Science ®Google Scholar
• Sudhir PR, Chen CH, Kumari MP, et al. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells. Mol Cell Proteomics. 2012;11:901–915.
   PubMed Web of Science ®Google Scholar
• Moradian A, Kalli A, Sweredoski MJ, et al. The top-down, middle-down, and bottom-up mass spectrometry approaches for characterization of histone variants and their post-translational modifications. Proteomics. 2014;14:489–497.
   PubMed Web of Science ®Google Scholar
• Bell C, Smith GT, Sweredoski MJ, et al. Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research. J Proteome Res. 2012;11:119–130.
   PubMed Web of Science ®Google Scholar
• Poschmann G, Sitek B, Sipos B, et al. Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol Cell Proteomics. 2009;8:1105–1116.
   PubMed Web of Science ®Google Scholar
• Megger DA, Bracht T, Meyer HE, et al. Label-free quantification in clinical proteomics. Biochim Biophys Acta. 2013;1834:1581–1590.
   PubMed Web of Science ®Google Scholar
• Indovina P, Marcelli E, Pentimalli F, et al. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. Mass Spectrom Rev. 2013;32:129–142.
   PubMed Web of Science ®Google Scholar
• Lin SY, Hsu WH, Lin CC, et al. Mass spectrometry-based proteomics in chest medicine, gerontology, and nephrology: subgroups omics for personalized medicine. Biomedicine. 2014;4:25–36.
   PubMedGoogle Scholar
• Fujii K, Nakamura H, Nishimura T. Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma. Expert Rev Proteomics. 2017;14:373–386.
   PubMed Web of Science ®Google Scholar
• Mehaffy C, Hess A, Prenni JE, et al. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics. 2010;10:1966–1984.
   PubMed Web of Science ®Google Scholar
• Zeng GQ, Zhang PF, Deng X, et al. Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics. 2012;11:M111.013946.
   Web of Science ®Google Scholar
• Nakayama N, Bando Y, Fukuda T, et al. Developments of mass spectrometry-based technologies for effective drug development linked with clinical proteomes. Drug Metab Pharmacokinet. 2016;31:3–11.
   PubMed Web of Science ®Google Scholar
• Xu YM, Wu DD, Zheng W, et al. Proteome profiling of cadmium-induced apoptosis by antibody array analyses in human bronchial epithelial cells. Oncotarget. 2015;7:6146–6158.
   Web of Science ®Google Scholar
• Xu YM, Gao YM, Wu DD, et al. Aberrant cytokine secretion and zinc uptake in chronic cadmium-exposed lung epithelial cells. Proteomics Clin Appl. 2017;11:1600059.
   Web of Science ®Google Scholar
• Sjöberg R, Mattsson C, Andersson E, et al. Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling. Nat Biotechnol. 2016;33:582–592.
   Google Scholar
• Jakobsen KR, Paulsen BS, Bæk R, et al. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracell Vesicles. 2015;4:26659.
   PubMed Web of Science ®Google Scholar
• Zlobec I, Suter G, Perren A, et al. Next-generation tissue microarrays (ngTMA) in translational research. New Horiz Transl Med. 2015;2:58–59.
   Google Scholar
• Hasan MM, Zhou Y, Lu X, et al. Computational identification of protein pupylation sites by using profile-based composition of k-spaced amino acid pairs. PLoS One. 2015;10:e0129635.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen L, Li B. A new protein-protein interaction prediction algorithm based on conditional random field. Cham (Switzerland): Springer International Publishing; 2015.
   Google Scholar
• Wenger CD, Coon JJ. A proteomics search algorithm specifically designed for high-resolution tandem mass spectra. J Proteome Res. 2013;12:1377–1386.
   PubMed Web of Science ®Google Scholar
• Gromiha MM, Ou YY. Bioinformatics approaches for functional annotation of membrane proteins. Brief Bioinform. 2014;15:155–168.
   PubMed Web of Science ®Google Scholar
• Chen C, Huang H, Wu CH. Protein bioinformatics databases and resources. Vol. 1558. New York (NY): Springer; 2017.
   Google Scholar
• Facchiano A. Bioinformatic resources for the investigation of proteins and proteomes. Peptidomics. 2017;3:1–10.
   Google Scholar
• Holliday GL, Bairoch A, Bagos PG, et al. Key challenges for the creation and maintenance of specialist protein resources. Proteins. 2015;83:1005–1013.
   PubMed Web of Science ®Google Scholar
• Cortinovis D, Abbate M, Bidoli P, et al. Targeted therapies and immunotherapy in non-small-cell lung cancer. Ecancermedicalscience. 2016;10:648.
   PubMed Web of Science ®Google Scholar
• Ilse P, Biesterfeld S, Pomjanski N, et al. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis. Cancer Genomics Proteomics. 2014;11:251–258.
   PubMed Web of Science ®Google Scholar
• Sundarraj S, Kannan S. Immunohistochemical expression of cytosolic phospholipase A2α in non-small cell lung carcinoma. Asian Pac J Cancer Prev. 2010;11:1367–1372.
   PubMedGoogle Scholar
• Pastor MD, Nogal A, Molina-Pinelo S, et al. Proteomic biomarkers in lung cancer. Clin Transl Oncol. 2013;15:671–682.
   PubMed Web of Science ®Google Scholar
• Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192:639–648.
   PubMed Web of Science ®Google Scholar
• Gharib TG, Chen G, Wang H, et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia. 2002;4:440–448.
   PubMed Web of Science ®Google Scholar
• Dowling P, Pollard D, Larkin A, et al. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Mol Biosyst. 2015;11:743–752.
   PubMed Web of Science ®Google Scholar
• Spiess PC, Deng B, Hondal RJ, et al. Proteomic profiling of acrolein adducts in human lung epithelial cells. J Proteomics. 2011;74:2380–2394.
   PubMed Web of Science ®Google Scholar
• Li L, Lu Y, Stemmer PM, et al. Filamin A phosphorylation by Akt promotes cell migration in response to arsenic. Oncotarget. 2015;6:12009–12019.
   PubMed Web of Science ®Google Scholar
• Zeng GQ, Yi H, Zhang PF, et al. The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process. PLoS One. 2013;8:e71865.
   PubMed Web of Science ®Google Scholar
• Ge Y, Bruno M, Wallace K, et al. Proteome profiling reveals potential toxicity and detoxification pathways following exposure of BEAS-2B cells to engineered nanoparticle titanium dioxide. Proteomics. 2011;11:2406–2422.
   PubMed Web of Science ®Google Scholar
• Chen DJ, Xu YM, Zheng W, et al. Proteomic analysis of secreted proteins by human bronchial epithelial cells in response to cadmium toxicity. Proteomics. 2015;15:3075–3086.
   PubMed Web of Science ®Google Scholar
• Clark DJ, Fondrie WE, Yang A, et al. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes. J Proteomics. 2016;133:161–169.
   PubMed Web of Science ®Google Scholar
• Choi DY, You S, Jung JH, et al. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment. Proteomics. 2014;14:1845–1856.
   PubMed Web of Science ®Google Scholar
• Park JE, Tan HS, Datta A, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010;9:1085–1099.
   PubMed Web of Science ®Google Scholar
• Gao H, Niu Y, Li M, et al. Identification of DJ-1 as a contributor to multidrug resistance in human small‐cell lung cancer using proteomic analysis. Int J Exp Pathol. 2017;98:67–74.
   PubMed Web of Science ®Google Scholar
• Wang K, Li H, Chen R, et al. Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer. Oncotarget. 2017. Epub. DOI:10.18632/oncotarget.18547
   Google Scholar
• Cao X, Tang Z, Huang F, et al. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer. Oncotarget. 2017;8:12812–12819.
   PubMed Web of Science ®Google Scholar
• Li Y, Fan S, Koo J, et al. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer. Rev Med Chil. 2012;127:1439–1446.
   Google Scholar
• Martín-Bernabé A, Cortés R, Lehmann SG, et al. Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer. J Proteome Res. 2014;13:4695–4704.
   PubMed Web of Science ®Google Scholar
• van der Wekken AJ, Hiltermann TJ, Groen HJ. The value of proteomics in lung cancer. Ann Transl Med. 2015;3:29.
   PubMed Web of Science ®Google Scholar
• Gadgeel S, Goss G, Soria JC, et al. Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. Lung Cancer. 2017;109:101–108.
   PubMed Web of Science ®Google Scholar
• Jung YJ, Katilius E, Ostroff RM, et al. Development of a protein biomarker panel to detect non–small-cell lung cancer in Korea. Clin Lung Cancer. 2017;18:e99–107.
   PubMed Web of Science ®Google Scholar
• Coverley D, Higgins G, West D, et al. A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma. Clin Biochem. 2017;50:336–343.
   PubMed Web of Science ®Google Scholar
• López-Sánchez LM, Jurado-Gámez B, Feu-Collado N, et al. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. Am J Physiol Lung Cell Mol Physiol. 2017;313:L664–L676. Epub: ajplung.00119.2017.
   PubMed Web of Science ®Google Scholar
• Li QK, Shah P, Li Y, et al. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. J Proteome Res. 2013;12:3689–3696.
   PubMed Web of Science ®Google Scholar
• Clark DJ, Mei Y, Sun S, et al. Glycoproteomic approach identifies KRAS as a positive regulator of CREG1 in non-small cell lung cancer cells. Theranostics. 2016;6:65–77.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53:128–149.
   PubMed Web of Science ®Google Scholar
• Chen YWR, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One. 2016;11:e0158843.
   PubMed Web of Science ®Google Scholar
• Paone G, Leone V, Conti V, et al. Blood and sputum biomarkers in COPD and asthma: a review. Eur Rev Med Pharmacol Sci. 2016;20:698–708.
   PubMed Web of Science ®Google Scholar
• Ongay S, Klont F, Horvatovich P, et al. Prioritization of COPD protein biomarkers, based on a systematic study of the literature. Adv Precis Med. 2016;1:12–24.
   Google Scholar
• Ohlmeier S, Nieminen P, Gao J, et al. Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2016;310:L1155–1165.
   PubMed Web of Science ®Google Scholar
• Carleo A, Chorostowskawynimko J, Koeck T, et al. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency? Int J Chron Obstruct Pulmon Dis. 2017;12:829–837.
   PubMed Web of Science ®Google Scholar
• Willemse BW, ten Hacken NH, Rutgers B, et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J. 2005;26:835–845.
   PubMed Web of Science ®Google Scholar
• Kim V, Oros M, Durra H, et al. Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction. PLoS One. 2015;10:e0116108.
   PubMed Web of Science ®Google Scholar
• Vassallo R, Walters PR, Lamont J, et al. Cigarette smoke promotes dendritic cell accumulation in COPD; a lung tissue research consortium study. Respir Res. 2010;11:1–13.
   PubMed Web of Science ®Google Scholar
• Titz B, Sewer A, Schneider T, et al. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects. J Proteomics. 2015;128:306–320.
   PubMed Web of Science ®Google Scholar
• Iadarola P, Viglio S. Spit it out! How could the sputum proteome aid clinical research into pulmonary diseases? Expert Rev Proteomics. 2017;14:391–393.
   PubMed Web of Science ®Google Scholar
• Diao W, Shen N, Du Y, et al. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:1549–1564.
   PubMed Web of Science ®Google Scholar
• Truedsson M, Malm J, Barbara SK, et al. Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study. Clin Transl Med. 2016;5:1–6.
   PubMed Web of Science ®Google Scholar
• Pastor MD, Nogal A, Molinapinelo S, et al. Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics. 2013;89:227–237.
   PubMed Web of Science ®Google Scholar
• Sundar IK, Nevid MZ, Friedman AE, et al. Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer. J Proteome Res. 2014;13:982–996.
   PubMed Web of Science ®Google Scholar
• Tuberculosis [Internet]. World Health Organization. [updated 2017 Mar; cited 2017 Oct]. Available from: http://www.who.int/mediacentre/factsheets/fs104/en/
   Google Scholar
• Mehaffy MC, Kruhgarcia NA, Dobos KM. Prospective on Mycobacterium tuberculosis proteomics. J Proteome Res. 2012;11:17–25.
   PubMed Web of Science ®Google Scholar
• Hawn TR, Day TA, Scriba TJ, et al. Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev. 2014;78:650–671.
   PubMed Web of Science ®Google Scholar
• Bozzano F, Marras F, De Maria A. Immunology of tuberculosis. Mediterr J Hematol Infect Dis. 2014;6:e2014027.
   PubMedGoogle Scholar
• Kuo CP, Chang KS, Hsu JL, et al. Analysis of the immune response of human dendritic cells to Mycobacterium tuberculosis by quantitative proteomics. Proteome Sci. 2016;14:1–11.
   PubMed Web of Science ®Google Scholar
• Dubaniewicz A, Holownia A, Kalinowski L, et al. Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen? Hum Immunol. 2013;74:45–51.
   PubMed Web of Science ®Google Scholar
• Xu DD, Deng DF, Li X, et al. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ‐coupled two‐dimensional LC‐MS/MS. Proteomics. 2014;14:322–331.
   PubMed Web of Science ®Google Scholar
• Jiang TT, Shi LY, Wei LL, et al. Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis. PLoS One. 2017;12:e0173304.
   PubMed Web of Science ®Google Scholar
• Singh A, Gupta AK, Gopinath K, et al. Evaluation of 5 novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results. Sci Rep. 2017;7:44121.
   PubMed Web of Science ®Google Scholar
• Nagai H, Suzukawa M, Sakakibara Y, et al. Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients. J Immunol Res. 2014;2014:764028.
   PubMedGoogle Scholar
• De Groote MA, Higgins M, Hraha T, et al. Highly multiplexed proteomic analysis of Quantiferon supernatants to identify biomarkers of latent tuberculosis infection. J Clin Microbiol. 2017;55:391–402.
   PubMed Web of Science ®Google Scholar
• Kumar NP, Velayutham B, Nair D, et al. Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2017;21:93–99.
   PubMed Web of Science ®Google Scholar
• Won EJ, Choi JH, Cho YN, et al. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease. J Infect. 2017;74:281–293.
   PubMed Web of Science ®Google Scholar
• Kamakia R, Kiazyk S, Waruk J, et al. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2017;21:278–285.
   PubMed Web of Science ®Google Scholar
• Målen H, De Souza GA, Pathak S, et al. Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiol. 2011;11:18.
   PubMed Web of Science ®Google Scholar
• Målen H, Pathak S, Søfteland T, et al. Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol. 2010;10:132.
   PubMed Web of Science ®Google Scholar
• Peters JS, Calder B, Gonnelli G, et al. Identification of quantitative proteomic differences between Mycobacterium tuberculosis lineages with altered virulence. Front Microbiol. 2016;7:813.
   PubMed Web of Science ®Google Scholar
• Sinha S, Kosalai K, Arora S, et al. Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology. 2005;151:2411–2419.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Chalmers MJ, Gao FP, et al. Identification of Mycobacterium tuberculosis H37Rv integral membrane proteins by one-dimensional gel electrophoresis and liquid chromatography electrospray ionization tandem mass spectrometry. J Proteome Res. 2005;4:855–861.
   PubMed Web of Science ®Google Scholar
• Prisic S, Dankwa S, Schwartz D, et al. Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc Natl Acad Sci USA. 2010;107:7521–7526.
   PubMed Web of Science ®Google Scholar
• White MJ, Savaryn JP, Bretl DJ, et al. The HtrA-Like serine protease PepD interacts with and modulates the Mycobacterium tuberculosis 35-kDa antigen outer envelope protein. PLoS One. 2011;6:e18175.
   PubMedGoogle Scholar
• Poulsen C, Akhter Y, Jeon AH, et al. Proteome-wide identification of mycobacterial pupylation targets. Mol Syst Biol. 2010;6:386.
   PubMed Web of Science ®Google Scholar
• Singh A, Gupta AK, Gopinath K, et al. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis. Int J Mycobacteriol. 2016;5(Suppl 1):S123–S124.
   PubMedGoogle Scholar
• Goletti D, Petruccioli E, Joosten SA, et al. Tuberculosis biomarkers: from diagnosis to protection. Infect Dis Rep. 2016;8:6568.
   PubMed Web of Science ®Google Scholar
• Yerlikaya S, Broger T, Maclean E, et al. A tuberculosis biomarker database: the key to novel TB diagnostics. Int J Infect Dis. 2017;56:253–257.
   PubMed Web of Science ®Google Scholar
• Nie S, Zhang H, Mayer KM, et al. Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis. PLoS One. 2015;10:e0135237.
   PubMed Web of Science ®Google Scholar
• Meng X, Clews J, Kargas V, et al. The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability. Cell Mol Life Sci. 2017;74:1–16.
   PubMed Web of Science ®Google Scholar
• Sloane AJ, Lindner RA, Prasad SS, et al. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med. 2005;172:1416–1426.
   PubMed Web of Science ®Google Scholar
• Farrell PM, White TB, Ren CL, et al. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr. 2017;181S:S4–15.
   PubMed Web of Science ®Google Scholar
• Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18:509–519.
   PubMed Web of Science ®Google Scholar
• Abdullah LH, Evans JR, Wang TT, et al. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight. 2017;2:e89752.
   PubMed Web of Science ®Google Scholar
• Trzcińska-Daneluti AM, Chen A, Nguyen L, et al. RNA interference screen to identify kinases that suppress rescue of ΔF508-CFTR. Mol Cell Proteomics. 2015;14:1569–1583.
   PubMed Web of Science ®Google Scholar
• Peters-Hall JR, Brown KJ, Pillai DK, et al. Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome. Am J Respir Cell Mol Biol. 2015;53:22–32.
   PubMed Web of Science ®Google Scholar
• DeBoer EM, Kroehl M, Wagner BD, et al. Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis. Proteomics Clin Appl. 2017;11:1600147.
   Web of Science ®Google Scholar
• Assani K, Shrestha CL, Robledo-Avila F, et al. Human cystic fibrosis macrophages have defective calcium-dependent protein kinase C activation of the NADPH oxidase, an effect augmented by Burkholderia cenocepacia. J Immunol. 2017;198:1985–1994.
   PubMed Web of Science ®Google Scholar
• Laval J, Ralhan A, Hartl D. Neutrophils in cystic fibrosis. Thorax. 2016;397:485–496.
   Google Scholar
• Veit G, Bossard F, Goepp J, et al. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol Biol Cell. 2012;23:4188–4202.
   PubMed Web of Science ®Google Scholar
• Negm OH, Hamed MR, Dilnot EM, et al. Profiling humoral immune responses to clostridium difficile-specific antigens by protein microarray analysis. Clin Vaccine Immunol. 2015;22:1033–1039.
   PubMed Web of Science ®Google Scholar
• Peri C, Gori A, Gagni P, et al. Evolving serodiagnostics by rationally designed peptide arrays: the Burkholderia paradigm in cystic fibrosis. Sci Rep. 2016;6:32873.
   PubMed Web of Science ®Google Scholar
• Raju SV, Lin VY, Liu L, et al. The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke. Am J Respir Cell Mol Biol. 2017;56:99–108.
   PubMed Web of Science ®Google Scholar
• Flume PA, Liou TG, Borowitz DS, et al. Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation. Chest. 2012;142:718–724.
   PubMed Web of Science ®Google Scholar
• Hisert KB, Schoenfelt KQ, Cooke G, et al. Ivacaftor-induced proteomic changes suggest monocyte defects may contribute to the pathogenesis of cystic fibrosis. Am J Respir Cell Mol Biol. 2016;54:594–597.
   PubMed Web of Science ®Google Scholar
• Zhong J, Cui Y, Guo J, et al. Resolving chromosome-centric human proteome with translating mRNA analysis: a strategic demonstration. J Proteome Res. 2014;13:50–59.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Huang X, Kelleher NL. Epiproteomics: quantitative analysis of histone marks and codes by mass spectrometry. Curr Opin Chem Biol. 2016;33:142–150.
   PubMed Web of Science ®Google Scholar
• Xu YM, Yu FY, Lau AT. Discovering epimodifications of the genome, transcriptome, proteome, and metabolome: the quest for conquering the uncharted epi(c) territories. Curr Pharmacol Rep. 2017;3:286–293.
   Google Scholar
• Lefrançais E, Ortizmuñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105–109.
   PubMed Web of Science ®Google Scholar
• Luo S, Wang Y, An Q, et al. Platelets protect lung from injury induced by systemic inflammatory response. Sci Rep. 2017;7:42080.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Faussonepellegrini MS. TELOCYTES – a case of serendipity: the winding way from interstitial cells of cajal (ICC), via interstitial cajal-like cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010;14:729–740.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Cretoiu D, Yan G, et al. Comparative proteomic analysis of human lung telocytes with fibroblasts. J Cell Mol Med. 2014;18:568–589.
   PubMed Web of Science ®Google Scholar
• Shi L, Dong N, Chen C, et al. Potential roles of telocytes in lung diseases. Semin Cell Dev Biol. 2016;55:31–39.
   PubMed Web of Science ®Google Scholar
• Song D, Cretoiu D, Cretoiu SM, et al. Telocytes and lung disease. Histol Histopathol. 2016;31:1303–1314.
   PubMed Web of Science ®Google Scholar
• Teran LM, Montes-Vizuet R, Li X, et al. Respiratory proteomics: from descriptive studies to personalized medicine. J Proteome Res. 2015;14:38–50.
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Agusti A, Roche N, et al. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385:1789–1798.
   PubMed Web of Science ®Google Scholar
• Nice EC. From proteomics to personalized medicine: the road ahead. Expert Rev Proteomics. 2016;13:341–343.
   PubMed Web of Science ®Google Scholar
• Chen R, Mias GI, Lipookthan J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293–1307.
   PubMed Web of Science ®Google Scholar
• Bosch B, Bilton D, Sosnay P, et al. Ethnicity impacts the cystic fibrosis diagnosis: a note of caution. J Cyst Fibros. 2017;16:488–491.
   PubMed Web of Science ®Google Scholar
• Andreu-Perez J, Poon CC, Merrifield RD, et al. Big data for health. IEEE J Biomed Health Inform. 2015;19:1193–1208.
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Vogelstein JT, Parmigiani G, et al. The predictive capacity of personal genome sequencing. Sci Transl Med. 2012;4:133ra58.
   PubMed Web of Science ®Google Scholar
• Rahman SM, Ji X, Zimmerman LJ, et al. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight. 2016;1:e88814.
   PubMed Web of Science ®Google Scholar